| Literature DB >> 30761002 |
Ying Liu1, Xia Zhang1, Jingpu Zhang2, Changqin Hu1.
Abstract
Cephalosporins are beta-lactam antibiotics that are widely used in China. Five generations of cephalosporins have been introduced in clinical practice to date; moreover, some new candidates are also undergoing clinical evaluations. To improve the success rates of new drug development, we need to have a comprehensive understanding about the relationship between the structure of cephalosporins and the toxicity that it induces at an early stage. In the cephalosporins toxicity study using zebrafish, the drug absorption is a key point. In this study, we determined the absorption of cephalosporins in zebrafish during toxicity test. The internal concentrations of 19 cephalosporins in zebrafish were determined using a developed liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Furthermore, a quantitative structure-activity relationship (QSAR) model was established by multilinear regression; moreover, it was used to predict the absorption of cephalosporins in zebrafish. During leave-one-out cross-validation, a satisfactory performance was obtained with a predictive ability (q 2) of 0.839. The prediction ability of the model was further confirmed when the predictive ability (q 2) was 0.859 in external prediction. The best QSAR model, which was based on five molecular descriptors, exhibited a promising predictive performance and robustness. In experiments involving drug toxicity, the developed QSAR model was used to estimate internal concentrations of cephalosporins. Thus, the toxicity results were correlated with the internal concentration of the drug within the larvae. The developed model served as a new powerful tool in zebrafish toxicity tests.Entities:
Keywords: QSAR; absorption; cephalosporin; liquid chromatography/tandem mass spectrometry; toxicity; zebrafish
Year: 2019 PMID: 30761002 PMCID: PMC6361752 DOI: 10.3389/fphar.2019.00031
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Molecular formula and MRM parameters of each analyte.
| Drug | Molecular formula | Precursor ion (m/z) | Product ion (m/z) | DP (V) | CE (eV) | CXP (V) |
|---|---|---|---|---|---|---|
| Cefalexin | C16H17N3O4S | 348 | 106 | 40 | 34 | 10 |
| Cefradine | C16H19N3O4S | 350 | 176 | 45 | 40 | 11 |
| Cefadroxil | C16H17N3O5S | 364 | 114 | 35 | 40 | 9 |
| Cefaclor | C15H14ClN3O4S | 368 | 106 | 50 | 27 | 11 |
| Ceftizoxime | C13H13N5O5S2 | 384 | 126 | 48 | 45 | 10 |
| Cefuroxime | C16H16N4O8S | 442 | 364 | 21 | 20 | 9 |
| Cefoxitin | C16H17N3O7S2 | 445 | 215 | 26 | 30 | 10 |
| Ceftezole | C13H12N8O4S3 | 441 | 156 | 46 | 26 | 8 |
| Cefazolin | C14H14N8O4S3 | 455 | 156 | 48 | 25 | 13 |
| Cefotaxime | C16H17N5O7S2 | 456 | 167 | 65 | 27 | 9 |
| Cefathiamidine | C19H28N4O6S2 | 473 | 159 | 61 | 50 | 12 |
| Flomoxef | C15H18F2N6O7S2 | 497 | 122 | 50 | 61 | 10 |
| Cefmenoxime | C16H17N9O5S3 | 512 | 324 | 45 | 28 | 11 |
| Cefpirome | C22H22N6O5S2 | 515 | 396 | 50 | 15 | 5 |
| Cefminox | C16H21N7O7S3 | 520 | 161 | 65 | 28 | 9 |
| Cefotiam | C18H23N9O4S3 | 526 | 174 | 61 | 50 | 10 |
| Ceftazidime | C22H22N6O7S2 | 547 | 167 | 45 | 40 | 10 |
| Cefodizime | C20H20N6O7S4 | 585 | 125 | 40 | 75 | 11 |
| Cefoperazone | C25H27N9O8S2 | 646 | 290 | 57 | 36 | 10 |
| Clenbuterol (IS) | C12H18Cl2N2O | 277 | 203 | 35 | 23 | 8 |
Calibration curve and absorption results of zebrafish.
| Internal concentration (mM × 10-5) | |||||
|---|---|---|---|---|---|
| Drug | Calibration curve | r | 0.28 mM | 1 mM | 2 mM |
| Cefalexin | 0.9962 | 1.01 | 5.48 | 16.83 | |
| Cefradine | 0.9918 | 3.15 | 8.93 | 19.89 | |
| Cefadroxil | 0.9967 | 1.32 | 7.07 | 12.55 | |
| Cefaclor | 0.9959 | 1.01 | 3.43 | 9.49 | |
| Ceftizoxime | 0.9969 | 1.17 | 3.70 | 13.15 | |
| Ceftezole | 0.9948 | 3.95 | 7.08 | 12.96 | |
| Cefuroxime | 0.9950 | 0.68 | 1.55 | 4.66 | |
| Cefoxitin | 0.9899 | 2.22 | 12.73 | 18.39 | |
| Cefazolin | 0.9969 | 8.56 | 13.95 | 14.19 | |
| Cefotaxime | 0.9962 | 0.27 | 0.75 | 0.82 | |
| Cefathiamidine | 0.9969 | 0.49 | 1.29 | 1.63 | |
| Flomoxef | 0.9953 | 1.07 | 8.30 | 11.54 | |
| Cefmenoxime | 0.9976 | 0.00 | 0.71 | 1.14 | |
| Cefpirome | 0.9969 | 0.21 | 0.86 | 1.67 | |
| Cefminox | 0.9960 | 1.01 | 8.26 | 14.78 | |
| Cefotiam | 0.9935 | 0.25 | 1.31 | 3.73 | |
| Ceftazidime | 0.9981 | 0.00 | 2.45 | 5.47 | |
| Cefodizime | 0.9959 | 0.51 | 0.94 | 3.47 | |
| Cefoperazone | 0.9986 | 1.30 | 5.75 | 12.47 | |
FIGURE 1The dose-internal concentration curves were obtained for 19 cephalosporins.
The existing form and k-value of each drug.
| No. | Name | The existing form in zebrafish | No. | Name | The existing form in zebrafish | ||
|---|---|---|---|---|---|---|---|
| (1) | Cefathiamidine | 0.6439 | (11) | Cefodizime | 1.7709 | ||
| (2) | Cefradine | 9.8110 | (12) | Cefuroxime | 2.3643 | ||
| (3) | Cefotiam | 2.0488 | (13) | Cefpirome | 0.1689 | ||
| (4) | Cefoperazone | 6.5063 | (14) | Ceftazidime | 3.1702 | ||
| (5) | Cefadroxil | 6.4617 | (15) | Cefotaxime | 0.3023 | ||
| (6) | Cefaclor | 5.0027 | (16) | Ceftizoxime | 7.1156 | ||
| (7) | Ceftezole | 5.2798 | (17) | Cefmenoxime | 0.6493 | ||
| (8) | Flomoxef | 5.9111 | (18) | Cefalexin | 9.3280 | ||
| (9) | Cefminox | 7.9122 | (19) | Cefazolin | 3.0851 | ||
| (10) | Cefoxitin | 9.1638 | / | / | / | / | |
FIGURE 2The plot of the observed k-value vs. the predicted k-value of the training set.
The meaning and p-value of each five molecular descriptors in the final model.
| Molecular descriptor | Meaning | |
|---|---|---|
| HBD_Count | Number of hydrogen bond donating groups in the molecule. It is calculated using substructure queries to count the number of times the queries match structural features in the molecule | 2.923e-02 |
| Jurs_WPSA_1 | Surface-weighted charged partial surface areas. Set of six descriptors obtained by multiplying descriptors 1–6 by the total molecular solvent-accessible surface area and dividing by 100 | 2.542e-03 |
| Num_AliphaticSingleBonds | Single bonds in aliphatic systems | 1.928e-05 |
| Num_AromaticBonds | Bonds in aromatic ring systems | 2.294e-03 |
| QED_MW | Molecular weight contribution to the quantitative estimate of drug-likeness (QED) score | 2.054e-05 |
FIGURE 3The 3D conformations of the 19 analogs in zebrafish.